ite Pharma via AP
In this May 2016 photo provided by Kite Pharma, cell therapy specialists at the company’s manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in the lab to fight cancer. The therapy, called CAR-T cell, turns a patient’s own blood cells into specialized cancer killers. (Kite Pharma via AP) 
Getting your player ready...
A process of taking patients’ own cells and reprogramming them to fight cancer has been a last-ditch resort for blood cancer patients, but a study in Aurora is trying to determine if more patients could benefit from trying them sooner.
Already have an account Log In
This article is only available to subscribers
Trusted Local News
Standard Digital
$1 for 1 year
Offer valid for non-subscribers only
